437 results on '"Schrader, Kasmintan A."'
Search Results
2. Optimising clinical care through CDH1-specific germline variant curation: improvement of clinical assertions and updated curation guidelines
3. “I just wanted more”: Hereditary cancer syndromes patients’ perspectives on the utility of circulating tumour DNA testing for cancer screening
4. Improving Access to Hereditary Testing in Pancreatic Ductal Carcinoma
5. Genetics Adviser: The development and usability testing of a new patient digital health application to support clinical genomic testing
6. Defining the heterogeneity of unbalanced structural variation underlying breast cancer susceptibility by nanopore genome sequencing
7. Great expectations: patients’ preferences for clinically significant results from genomic sequencing
8. “I don’t need any more unknowns hanging over my head”: Views of patients with cancer on variants of uncertain significance and low/moderate risk results from genomic sequencing
9. A comprehensive genomic reporting structure for communicating all clinically significant primary and secondary findings
10. How do members of the public expect to use variants of uncertain significance in their health care? A population-based survey
11. Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care
12. Patient ethnicity and cascade genetic testing: a descriptive study of a publicly funded hereditary cancer program
13. Patient and public preferences for being recontacted with updated genomic results: a mixed methods study
14. The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals
15. Beyond medically actionable results: an analytical pipeline for decreasing the burden of returning all clinically significant secondary findings
16. Long-Read Sequencing of an Advanced Cancer Cohort Resolves Rearrangements, Unravels Haplotypes, and Reveals Methylation Landscapes
17. Health-care practitioners’ preferences for the return of secondary findings from next-generation sequencing: a discrete choice experiment
18. Improved structural variant interpretation for hereditary cancer susceptibility using long-read sequencing
19. 2023 Canadian Urological Association guideline: Genetic testing in prostate cancer
20. Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy
21. Development of patient “profiles” to tailor counseling for incidental genomic sequencing results
22. Case–control analysis identifies shared properties of rare germline variation in cancer predisposing genes
23. “I don’t need any more unknowns hanging over my head”: Cancer patients’ views on variants of uncertain significance and low/moderate risk results from genomic sequencing
24. P892: “Should I let them know I have this?”: Concerns and experiences of genetic discrimination amongst individuals with hereditary cancer syndromes
25. P881: Revealing the hidden costs: Exploring the financial toxicity of hereditary cancer syndromes
26. P867: “I worry I don’t have control”: The psychosocial impacts of living with a hereditary cancer syndrome
27. P658: Detection of variant parent-of-origin in diverse hereditary cancer syndromes using only the proband’s blood sample
28. P555: Clinical utility returning of all types of medically relevant genomic sequencing findings: An observational study
29. P553: How do patients with hereditary cancer syndromes navigate the healthcare system? A qualitative comparative study across Canada
30. P538: Curious but cautious: Patients’ preferences for all types of clinically actionable genomic incidental results
31. P523: Returning all clinically relevant findings from genomic sequencing: Preliminary results from the incidental genomics RCT
32. P076: Implementing tumor-first genetic testing and parent-of-origin-aware genomic analysis into the diagnostic pipeline for hereditary breast cancer
33. A model for the return and referral of all clinically significant secondary findings of genomic sequencing
34. Data from A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer
35. Supplementary Figures 1 - 6, Tables 1 - 2 from A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer
36. Supplementary Table 5 from Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
37. Supplementary Information from Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
38. Optimising clinical care through CDH1-specific germline variant curation: improvement of clinical assertions and updated curation guidelines.
39. Testing for Hereditary Predisposition in Patients with Gynecologic Cancers, Quo Vadis?
40. Development and early‐stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient‐driven approach
41. P409: Clinical utility of genomic sequencing for hereditary cancer syndromes: An observational chart review
42. P375: Fragmented systems of care: An overview of Canadian health system care models for hereditary cancer syndromes
43. O35: Parent-of-origin-aware genomic analysis infers segregation of pathogenic variants in SDHD without parental data*
44. Parent-of-origin detection and chromosome-scale haplotyping using long-read DNA methylation sequencing and Strand-seq
45. P406: Partnering with patients to explore the psychosocial and socioeconomic impacts of hereditary cancer syndromes
46. P382: Professionals’ perspectives on the use of digital tools to support patient recontact in clinical genetics
47. Optimising clinical care throughCDH1-specific germline variant curation: improvement of clinical assertions and updated curation guidelines
48. Germline Testing and Somatic Tumor Testing forBRCA1/2Pathogenic Variants in Ovarian Cancer: What Is the Optimal Sequence of Testing?
49. Hereditary Diffuse Gastric Cancer
50. BRCA Mutation Testing for First-Degree Relatives of Women With High-Grade Serous Ovarian Cancer [4OP]
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.